News & Events

Keep up to date with the latest news and check out where our team will be headed this event season.

Recipharm AB Closes Acquisition of Vibalogics

Recipharm AB Closes Acquisition of Vibalogics Vibalogics, a contract development and manufacturing organization (CDMO) focused on the manufac…

Join us! World Vaccine Congress | April 18-21 | Washington DC

Location: Washington DC

Date: 04/18/2022 - 04/21/2022

Vibalogics and Recipharm will attend the World Vaccine Congress, April 18-21 2022, Marriott Marquis in Washington DC. The World Vaccine Congre…

Vibalogics Completes Major Milestone in $50M Cuxhaven Fac…

Vibalogics' expansion will provide added capacity and scalable clinical solutions for virotherapy manufacturing Vibalogics, a leading vir…

Vibalogics Acquired by Top Global CDMO Recipharm AB

Vibalogics Acquired by Top Global CDMO Recipharm AB Vibalogics, a contract development and manufacturing organization (CDMO), and an Ampersan…

Vibalogics Completes 118,000 ft² GMP Facility in Massachu…

New Massachusetts facility enables focused end-to-end virotherapy CDMO services Today, Vibalogics celebrates completion of the first ph…

The Medicine Maker: A New Focus for Cancer Therapeutics

The Medicine Maker recently featured Joe Sinclair, Vice President, Business Development & Corporate Strategy at Vibalogics exploring the t…